Document 0130 DOCN M9590130 TI Treatment with the alpha-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CD11a) by monoclonal antibodies. DT 9509 AU Bridges CG; Taylor DL; Kang MS; Brennan TM; Tyms AS; MRC Collaborative Centre, London, UK. SO Glycobiology. 1995 Mar;5(2):243-7. Unique Identifier : AIDSLINE MED/95299228 AB The antiviral clinical candidate 6-O-butanoyl castanospermine (MDL 28,574), an alpha-glucosidase 1 inhibitor, was examined for its effect on elementary parameters of immune function. It did not affect the mitogenic response of uninfected human mononuclear leukocytes or the detection of a range of cell surface markers, with the exception of the integrin LFA-1 (CD18/CD11a), which was reduced, after cell growth in vitro. The detection of LFA-1 was also reduced on both human and murine cells after oral administration of the compound to xenochimaeric or normal mice, respectively. Altered LFA-1 expression or function may contribute to reduced cell adhesion and the observed reduction in the in vitro allogeneic response by uninfected cells, as well as the previously described prevention of cell conjugate and HIV-induced syncytium formation. DE alpha-Glucosidases/*ANTAGONISTS & INHIB Animal Antibodies, Monoclonal Antigens, CD/*BIOSYNTHESIS/DRUG EFFECTS Antigens, CD18/*BIOSYNTHESIS Binding Sites, Antibody Cells, Cultured Gene Expression/DRUG EFFECTS Human Indolizines/*PHARMACOLOGY Interleukin-2/PHARMACOLOGY Lymphocyte Culture Test, Mixed Lymphocyte Function-Associated Antigen-1/*ANALYSIS/*BIOSYNTHESIS/ IMMUNOLOGY Lymphocyte Transformation Lymphocyte Transfusion Lymphocytes/DRUG EFFECTS/*IMMUNOLOGY Mice Mice, SCID Recombinant Proteins/PHARMACOLOGY Transplantation, Heterologous JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).